Growth hormone provocative test of 5 036 cases in pediatric clinic: a single center nursing / 中国实用护理杂志

ABSTRACT

Objective To explore the nursing experience of growth hormone provocative test in pediatric clinic. Methods Five thousand and thirty-six children with short stature or slowing growth received combined simultaneous Levodopa Pyridostigmine stimulation test from June 2008 to October 2018 in the Child Growth Center of the First Affiliated Hospital of SUN Yat- sen University. Comprehensive nursing intervention was conducted to ensure the test carry through successfully before, during and after the test. Results All children completed the five collections in the 120-minute growth hormone provocative test without cannula obstruction and blurt out. Some (986 out of 5 036 children, 19.58% ) had different degrees of adverse reactions including nausea,vomiting,abdominal pain, sweating,salivation,dizziness,pallor,etc.,most of which disappeared or alleviated after nursing, except 11 patients (0.22%) needed atropine muscular injection and 3 of whom needed intravenous fluids to release the marked symptoms. Conclusion Combined simultaneous Levodopa Pyridostigmine stimulation test is safe and practicable in pediatric clinics with nursing experience.